Advertisement

International Journal of Hematology

, Volume 85, Issue 3, pp 264–266 | Cite as

Successful Treatment of Primary Cardiac Lymphoma by Rituximab-CHOP and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation

  • Atsushi Nonami
  • Katsuto Takenaka
  • Kenjiro Kamezaki
  • Toshihiro Miyamoto
  • Naoki Harada
  • Koji Nagafuji
  • Takanori Teshima
  • Mine Harada
Case Report

Abstract

Primary cardiac lymphoma (PCL) is defined as lymphoma involving only the heart and/or pericardium, or with an intraperi-cardial location of the main tumor mass. It is an extremely rare type of lymphoma and has a poor prognosis because of diagnostic delay and the disease site. PCL is histologically characterized by a mostly diffuse large B-cell lymphoma. The median survival time has been reported to be 7 months. We present the case of a 55-year-old woman who presented with chest oppression and dyspnea on effort. Following a close examination, PCL with a high International Prognostic Index was diagnosed. She received 6 courses of R-CHOP therapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) and achieved complete remission. The patient then underwent a consolidation therapy consisting of high-dose chemotherapy including rituximab, followed by autologous peripheral blood stem cell transplantation. There were no complications, such as pulmonary embolism, fatal arrhythmia, or acute heart failure, throughout chemotherapy. Our experience indicates that this therapy is safe and effective and can improve the outcome of high-risk PCL.

Key words

Primary cardiac lymphoma Rituximab-CHOP Autologous peripheral blood stem cell transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McAllister HA, Fenoglio JJ. Tumors of the cardiovascular system. In:Atlas of Tumor Pathology, Series II, Fascicle 15. Washington, DC: Armed Forces Institute of Pathology; 1978;99–100.Google Scholar
  2. 2.
    Burke A, Virmani R. Tumors of the heart and great vessels. In: Rosai J, Sobin LH, eds.Atlas of Tumor Pathology, Series III, Fascicle 16. Washington, DC: Armed Forces Institute of Pathology;1996;171–179.Google Scholar
  3. 3.
    Rolla G, Bertero MT, Pastena G, et al. Primary lymphoma of the heart: a case report and review of the literature.Leuk Res. 2002;26:117–120.CrossRefGoogle Scholar
  4. 4.
    Maier BO, von Scheidt W, Sciuk J, et al. Cardiac involvement in malignancies: case 4. Primary cardiac diffuse large B-cell lymphoma: diagnosis by transesophageal echocardiography-guided transvenous biopsy.J Clin Oncol. 2004;22:2745–2747.CrossRefGoogle Scholar
  5. 5.
    Ceresoli GL, Ferreri AJ, Bucci E, Ripa C, Ponzoni M, Villa E.Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management.Cancer. 1997;80:1497–1506.CrossRefGoogle Scholar
  6. 6.
    Coiffier B, Lepage B, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.N Engl J Med. 2002;346:235–242.CrossRefGoogle Scholar
  7. 7.
    Haioun C, Lepage E, Gisselbrecht C, et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin’s lymphoma: final analysis of the prospective LNH87-2 protocol—a Groupe d’Etude des Lymphomes de l’Adulte study.J Clin Oncol. 2000;18:3025–3030.CrossRefGoogle Scholar
  8. 8.
    Chou T, Ishiguro T, Imajo K. A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin’s lymphoma. Japan Blood Cell Transplantation Study Group [in Japanese].Rinsho Ketsueki. 1999;40:1058–1067.PubMedGoogle Scholar
  9. 9.
    Ikeda H, Nakamura S, Nishimaki H, et al. Primary lymphoma of the heart: case report and literature review.Pathol Int. 2004;54:187–195.CrossRefGoogle Scholar
  10. 10.
    Chalabreysse L, Berger F, Loire R, Devouassoux G, Cordier JF,Thivolet-Bejui F. Primary cardiac lymphoma in immunocompetent patients: a report of three cases and review of the literature.Virchows Arch. 2002;441:456–461.CrossRefGoogle Scholar
  11. 11.
    Dawson MA, Mariani J, Taylor A, Koulouris G, Avery S. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP.Ann Oncol. 2006;17:176–177.CrossRefGoogle Scholar
  12. 12.
    Nakagawa Y, Ikeda U, Hirose M, et al. Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab).Circ J. 2004;68:172–173.CrossRefGoogle Scholar
  13. 13.
    Arimura K, Arima N, Hamada H, Kukita T, Matsushita K, Tei C.Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.Haematologica. 2003;88:ECR34.PubMedGoogle Scholar
  14. 14.
    Lo SS, Yeager AM, Peel RL, Katz WE, Ramanathan RK.Multimodality treatment in a case of primary cardiac lymphoma.Clin Lymphoma. 2003;4:112–114.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2007

Authors and Affiliations

  • Atsushi Nonami
    • 1
  • Katsuto Takenaka
    • 1
  • Kenjiro Kamezaki
    • 1
  • Toshihiro Miyamoto
    • 1
  • Naoki Harada
    • 1
  • Koji Nagafuji
    • 1
  • Takanori Teshima
    • 1
  • Mine Harada
    • 1
  1. 1.First Department of Internal Medicine, Graduate School of MedicineKyushu UniversityFukuokaJapan

Personalised recommendations